Filing Details
- Accession Number:
- 0001731122-21-000916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-19 08:47:25
- Reporting Period:
- 2021-05-17
- Accepted Time:
- 2021-05-19 08:47:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314052 | Anavex Life Sciences Corp. | AVXL | Services-Commercial Physical & Biological Research (8731) | 208365999 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1698234 | D.o. Peter Donhauser | 51 W 52Nd Street, 7Th Floor New York NY 10019-6163 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-17 | 1,000 | $10.93 | 2,165 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
